The DOI matches its Crossref record; 27 of the 28 references it cites were found in a registry or an index.
Endothelial-specific Nox2 overexpression increases vascular superoxide and macrophage recruitment in ApoE−/− mice
Open accessAbstract
AIMS: Vascular disease states are associated with endothelial dysfunction and increased production of reactive oxygen species derived from NADPH oxidases. However, it remains unclear whether a primary increase in superoxide production specifically in the endothelium alters the initiation or progression of atherosclerosis. METHODS AND RESULTS: Mice overexpressing Nox2 specifically in the endothelium (Nox2-Tg) were crossed with ApoE(-/-) mice to produce Nox2-Tg ApoE(-/-) mice and ApoE(-/-) littermates. Endothelial overexpression of Nox2 in ApoE(-/-) mice did not alter blood pressure, but significantly increased vascular superoxide production compared with ApoE(-/-) littermates, measured using both lucigenin chemiluminescence and 2-hydroxyethidium production (ApoE(-/-), 19.9 ± 6.3 vs. Nox2-Tg ApoE(-/-), 47.0 ± 7.0 nmol 2-hydroxyethidium/aorta, P< 0.05). Increased endothelial superoxide production increased endothelial levels of vascular cell adhesion protein 1 and enhanced macrophage recruitment in early lesions in the aortic roots of 9-week-old mice, indicating increased atherosclerotic plaque initiation. However, endothelial-specific Nox2 overexpression did not alter native or angiotensin II-driven atherosclerosis in either the aortic root or the descending aorta. CONCLUSION: Endothelial-targeted Nox2 overexpression in ApoE(-/-) mice is sufficient to increase vascular superoxide production and increase macrophage recruitment possible via activation of endothelial cells. However, this initial increase in macrophage recruitment did not alter the progression of atherosclerosis. These results indicate that Nox-mediated reactive oxygen species signalling has important cell-specific and distinct temporal roles in the initiation and progression of atherosclerosis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“However, in other cases, an increased expression of endothelial NOX2 has not been linked to pathological conditions even though an increased production of superoxide and macrophage recruitment was observed (243, 443).”
From Sources of Vascular Nitric Oxide and Reactive Oxygen Species and Their Regulation (2019) · cites this paper as [243]
In the citing paper
“The current paradigm indicates that macrophage NOX2 is more detrimental in the development of cardiovascular disease (395, 876), with endothelial NOX2 probably involved in the initiation, but not so much in the development of the disease, and a subsequent progress of the atherosclerotic lesion dependent on immune cells (243, 573, 976).”
From Sources of Vascular Nitric Oxide and Reactive Oxygen Species and Their Regulation (2019) · cites this paper as [243]
In the citing paper
“The current paradigm indicates that macrophage NOX2 is more detrimental in the development of cardiovascular disease (395, 876), with endothelial NOX2 probably involved in the initiation, but not so much in the development of the disease, and a subsequent progress of the atherosclerotic lesion dependent on immune cells (243, 573, 976).”
From Sources of Vascular Nitric Oxide and Reactive Oxygen Species and Their Regulation (2019) · cites this paper as [243]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress
Cai, H., & Harrison, D. G. (2000) · Circulation Research · doi:10.1161/01.res.87.10.840 · Cited by 3,839
ApoE-deficient mice develop lesions of all phases of atherosclerosis throughout the arterial tree.
Nakashima, Y., Plump, A. S., Raines, E. W., Breslow, J. L., & Ross, R. (1994) · Arteriosclerosis and Thrombosis: A Journal of Vascular Biology · doi:10.1161/01.atv.14.1.133 · Cited by 1,693
Mechanisms of Increased Vascular Superoxide Production in Human Diabetes Mellitus
Guzik, T. J., Mussa, S., Gastaldi, D., Sadowski, J., Ratnatunga, C., Pillai, R. G., & Channon, K. M. (2002) · Circulation · doi:10.1161/01.cir.0000012748.58444.08 · Cited by 979
Self-citationSuperoxide Production and Expression of Nox Family Proteins in Human Atherosclerosis
Sorescu, D., Weiss, D., Lassègue, B., Clempus, R. E., Szöcs, K., Sorescu, G. P., Valppu, L., Quinn, M. T., Lambeth, J. D., Vega, J. D., et al. (2002) · Circulation · doi:10.1161/01.cir.0000012917.74432.66 · Cited by 847
Lassègue, B., Sorescu, D., Szöcs, K., Yin, Q., Akers, M., Zhang, Y., Grant, S. L., Lambeth, J. D., & Griendling, K. K. (2001) · Circulation Research · doi:10.1161/hh0901.090299 · Cited by 839
NADPH Oxidases in Cardiovascular Health and Disease
Cave, A. C., Brewer, A. C., Narayanapanicker, A., Ray, R., Grieve, D. J., Walker, S., & Shah, A. M. (2006) · Antioxidants & Redox Signaling · doi:10.1089/ars.2006.8.691 · Cited by 630
Görlach, A., Brandes, R. P., Nguyen, K., Amidi, M., Dehghani, F., & Busse, R. (2000) · Circulation Research · doi:10.1161/01.res.87.1.26 · Cited by 598
NADPH Oxidases: Functions and Pathologies in the Vasculature
Lassègue, B., & Griendling, K. K. (2010) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.108.181610 · Cited by 592
Vascular Superoxide Production by NAD(P)H Oxidase
Guzik, T. J., West, N. E. J., Black, E., McDonald, D., Ratnatunga, C., Pillai, R. G., & Channon, K. M. (2000) · Circulation Research · doi:10.1161/01.res.86.9.e85 · Cited by 584
Self-citationPueyo, M. E., Gonzalez, W., Nicoletti, A., Savoie, F., Arnal, J., & Michel, J. (2000) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.20.3.645 · Cited by 523
Flagged first, then by citations
1 of the 28 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Reactive Oxygen Species in Metabolic and Inflammatory Signaling
Forrester, S. J., Kikuchi, D. S., Hernandes, M. S., Xu, Q., & Griendling, K. K. (2018) · Circulation Research · doi:10.1161/circresaha.117.311401 · Cited by 2,081
Roles of vascular oxidative stress and nitric oxide in the pathogenesis of atherosclerosis
Förstermann, U., Xia, N., & Li, H. (2017) · Circulation Research · doi:10.1161/circresaha.116.309326 · Cited by 1,519
Angiotensin II Signal Transduction: An Update on Mechanisms of Physiology and Pathophysiology
Forrester, S. J., Booz, G. W., Sigmund, C. D., Coffman, T. M., Kawai, T., Rizzo, V., Scalia, R. G., & Eguchi, S. (2018) · Physiological Reviews · doi:10.1152/physrev.00038.2017 · Cited by 1,135
Vascular oxidative stress, nitric oxide and atherosclerosis
Li, H., Horke, S., & Förstermann, U. (2014) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2014.09.001 · Cited by 678
Sources of Vascular Nitric Oxide and Reactive Oxygen Species and Their Regulation
Tejero, J., Shiva, S., & Gladwin, M. T. (2019) · Physiological Reviews · doi:10.1152/physrev.00036.2017 · Cited by 541
NADPH oxidases and oxidase crosstalk in cardiovascular diseases: novel therapeutic targets
Zhang, Y., Murugesan, P., Huang, K., & Cai, H. “. (2019) · Nature Reviews Cardiology · doi:10.1038/s41569-019-0260-8 · Cited by 551
NADPH Oxidases in Vascular Pathology
Konior, A., Schramm‐Luc, A., Cześnikiewicz‐Guzik, M., & Guzik, T. J. (2013) · Antioxidants and Redox Signaling · doi:10.1089/ars.2013.5607 · Cited by 464
Effects of shear stress on endothelial cells: go with the flow
Chistiakov, D. A., Orekhov, A. N., & Bobryshev, Y. V. (2016) · Acta Physiologica · doi:10.1111/apha.12725 · Cited by 453
Endothelial NADPH oxidases: which NOX to target in vascular disease?
Drummond, G. R., & Sobey, C. G. (2014) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2014.06.012 · Cited by 315
Uncoupling of endothelial NO synthase in atherosclerosis and vascular disease
Li, H., & Förstermann, U. (2013) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2013.01.006 · Cited by 285
Montezano, A. C. I., & Touyz, R. M. (2013) · Antioxidants and Redox Signaling · doi:10.1089/ars.2013.5302 · Cited by 280
Anti-Inflammatory Targets for the Treatment of Reperfusion Injury in Stroke
Mizuma, A., & Yenari, M. A. (2017) · Frontiers in Neurology · doi:10.3389/fneur.2017.00467 · Cited by 228
Wilson, A. J., Gill, E. K., Abudalo, R. A., Edgar, K. S., Watson, C. J., & Grieve, D. (2017) · Heart · doi:10.1136/heartjnl-2017-311448 · Cited by 178
The natural phenolic compounds as modulators of NADPH oxidases in hypertension
Yousefian, M., Shakour, N., Hosseinzadeh, H., Hayes, A. W., Hadizadeh, F., & Karimi, G. (2018) · Phytomedicine · doi:10.1016/j.phymed.2018.08.002 · Cited by 167
Update on Inflammatory Biomarkers and Treatments in Ischemic Stroke
Bonaventura, A., Liberale, L., Vecchié, A., Casula, M., Carbone, F., Dallegri, F., & Montecucco, F. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17121967 · Cited by 170
The Role of Oxidative Stress and Autophagy in Atherosclerosis
Perrotta, I. D., & Aquila, S. (2015) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2015/130315 · Cited by 148
NADPH oxidases: key modulators in aging and age-related cardiovascular diseases?
Sahoo, S., Meijles, D. N., & Pagano, P. J. (2016) · Clinical Science · doi:10.1042/cs20150087 · Cited by 147
Extra Virgin Olive Oil and Cardiovascular Diseases: Benefits for Human Health
Nocella, C., Cammisotto, V., Fianchini, L., D’Amico, A., Novo, M., Castellani, V., Stefanini, L., Violi, F., & Carnevale, R. (2017) · Endocrine Metabolic & Immune Disorders - Drug Targets · doi:10.2174/1871530317666171114121533 · Cited by 138
Maas, S. L., Soehnlein, O., & Viola, J. R. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02739 · Cited by 147
Fan, L. M., Douglas, G., Bendall, J. K., McNeill, E., Crabtree, M. J., Hale, A., Mai, A., Li, J., McAteer, M. A., Schneider, J. E., et al. (2014) · Circulation · doi:10.1161/circulationaha.113.005062 · Cited by 136
Self-citationAtherothrombosis and Oxidative Stress: Mechanisms and Management in Elderly
Violi, F., Loffredo, L., Carnevale, R., Pignatelli, P., & Pastori, D. (2017) · Antioxidants and Redox Signaling · doi:10.1089/ars.2016.6963 · Cited by 125
Redox signaling at the crossroads of human health and disease
Zuo, J., Zhang, Z., Luo, M., Zhou, L., Nice, E. C., Zhang, W., Wang, C., & Huang, C. (2022) · MedComm · doi:10.1002/mco2.127 · Cited by 123
Role of oxidative stress in calcific aortic valve disease and its therapeutic implications
Greenberg, H. Z. E., Zhao, G., Shah, A. M., & Zhang, M. (2021) · Cardiovascular Research · doi:10.1093/cvr/cvab142 · Cited by 115
Dihydromyricetin ameliorates atherosclerosis in LDL receptor deficient mice
Liu, T. T., Zeng, Y., Tang, K., Chen, X., Zhang, W., & Xu, X. L. (2017) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2017.05.003 · Cited by 100
NADPH Oxidase-2 and Atherothrombosis
Violi, F., Carnevale, R., Loffredo, L., Pignatelli, P., & Gallin, J. I. (2016) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.116.308351 · Cited by 102
Role of reactive oxygen species in atherosclerosis: Lessons from murine genetic models
Nègre‐Salvayre, A., Guerby, P., Gayral, S., Laffargue, M., & Salvayre, R. (2019) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2019.10.011 · Cited by 102
Effects of polystyrene nanoplastics on endothelium senescence and its underlying mechanism
Shiwakoti, S., Ko, J.-Y., Gong, D.-S., Dhakal, B., Lee, J.-H., Adhikari, R., Gwak, Y.-H., Park, S., Choi, I. J., Schini‐Kerth, V. B., et al. (2022) · Environment International · doi:10.1016/j.envint.2022.107248 · Cited by 98
Yang, X., Ding, Y., Sun, L., Shi, M., Zhang, P., Huang, Z., Wang, J., He, A., Wang, J., Wei, J., et al. (2022) · Redox Biology · doi:10.1016/j.redox.2022.102555 · Cited by 96
Oxidative Stress and Arterial Dysfunction in Peripheral Artery Disease
Ismaeel, A., Brumberg, R. S., Kirk, J. S., Papoutsi, E., Farmer, P. J., Bohannon, W. T., SMITH, R. S., Eidson, J. L., Sawicki, I., & Koutakis, P. (2018) · Antioxidants · doi:10.3390/antiox7100145 · Cited by 91
Overlapped Metabolic and Therapeutic Links between Alzheimer and Diabetes
Ahmad, W. (2012) · Molecular Neurobiology · doi:10.1007/s12035-012-8352-z · Cited by 80
Shafique, E., Torina, A. G., Reichert, K., Colantuono, B. J., Nur, N., Zeeshan, K., Ravichandran, V. S., Liu, Y., Feng, J., Zeeshan, K., et al. (2016) · Cardiovascular Research · doi:10.1093/cvr/cvw249 · Cited by 74
Gage, M., Yuldasheva, N. Y., Viswambharan, H., Sukumar, P., Cubbon, R. M., Galloway, S. L., Imrie, H., Skromna, A., Smith, J., Jackson, C. L., et al. (2013) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2013.06.017 · Cited by 66
El‐Mahdy, M. A., Ewees, M. G., Eid, M. S., Mahgoup, E. M., Khaleel, S. A., & Zweier, J. L. (2022) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00460.2021 · Cited by 69
Lai, S., Molfino, A., Testorio, M., Perrotta, A. M., Currado, A., Pintus, G., Pietrucci, D., Unida, V., Rocca, D. L., Biocca, S., et al. (2019) · Nutrients · doi:10.3390/nu11123006 · Cited by 63
Role of Oxidative Stress in the Pathogenesis of Atherothrombotic Diseases
Petrucci, G., Rizzi, A., Hatem, D., Tosti, G., Rocca, B., & Pitocco, D. (2022) · Antioxidants · doi:10.3390/antiox11071408 · Cited by 68
Current status of NADPH oxidase research in cardiovascular pharmacology
Álvarez, E., Rodiño-Janeiro, Paradela-Dobarro, Castiñeiras-Landeira, Raposeiras‐Roubín, S., & González‐Juanatey, J. R. (2013) · Vascular Health and Risk Management · doi:10.2147/vhrm.s33053 · Cited by 64
Zhao, Y., Liu, X., Tian, W., Guan, Y., Wang, P., & Miao, C. (2014) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.12273 · Cited by 62
Koya, T., Miyazaki, T., Watanabe, T., Shichiri, M., Atsumi, T., Kim‐Kaneyama, J., & Miyazaki, A. (2012) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00009.2012 · Cited by 61
Multitarget and promising role of dihydromyricetin in the treatment of metabolic diseases
Tong, H., Zhang, X., Tan, L., Jin, R., Huang, S., & Li, X. (2019) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2019.172888 · Cited by 63
NADPH Oxidases in Redox Regulation of Cell Adhesion and Migration
Schröder, K. (2013) · Antioxidants and Redox Signaling · doi:10.1089/ars.2013.5633 · Cited by 60
Saad, M. I., Abdelkhalek, T. M., Saleh, M. M., Kamel, M. A. E.-N., Youssef, M., Tawfik, S. H., & Domínguez, H. (2015) · Endocrine · doi:10.1007/s12020-015-0709-4 · Cited by 61
Li, M., Liu, X. Z., He, Y., Zheng, Q., Wang, M., Wu, Y. C., Zhang, Y., & Wang, C. (2017) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2017.01.027 · Cited by 59
Inhibition of NADPH Oxidase by Apocynin Attenuates Progression of Atherosclerosis
Kinkade, K. J., Streeter, J., & Miller, F. J. (2013) · International Journal of Molecular Sciences · doi:10.3390/ijms140817017 · Cited by 57
Reduced Atherosclerotic Burden in Subjects With Genetically Determined Low Oxidative Stress
Violi, F., Pignatelli, P., Pignata, C., Plebani, A., Rossi, P., Sanguigni, V., Carnevale, R., Soresina, A., Finocchi, A., Cirillo, E., et al. (2013) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.112.300438 · Cited by 57
Involvement of Nox2 NADPH Oxidase in Retinal Neovascularization
Chan, E. C., van Wijngaarden, P., Liu, G., Jiang, F., Peshavariya, H., & Dusting, G. J. (2013) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.13-12883 · Cited by 54
NADPH Oxidases in Diastolic Dysfunction and Heart Failure with Preserved Ejection Fraction
Teuber, J. P., Essandoh, K., Hummel, S. L., Madamanchi, N. R., & Brody, M. J. (2022) · Antioxidants · doi:10.3390/antiox11091822 · Cited by 55
Nox and Inflammation in the Vascular Adventitia
Meijles, D. N., & Pagano, P. J. (2015) · Hypertension · doi:10.1161/hypertensionaha.115.03622 · Cited by 54
Douglas, G., Hale, A., Patel, J., Chuaiphichai, S., Zen, A. A. H., Rashbrook, V. S., Trelfa, L., Crabtree, M. J., McNeill, E., & Channon, K. M. (2018) · Cardiovascular Research · doi:10.1093/cvr/cvy078 · Cited by 49
Self-citationKumar, S. K., & Mani, K. P. (2021) · Nitric Oxide · doi:10.1016/j.niox.2021.09.006 · Cited by 45
Sfyri, P., & Matsakas, A. (2017) · Journal of Biomedical Science · doi:10.1186/s12929-017-0346-8 · Cited by 44
Vascular transcriptional alterations produced by juvenile obesity in Ossabaw swine
Padilla, J., Jenkins, N. T., Lee, S., Zhang, H., Cui, J. G., Zuidema, M. Y., Zhang, C., Hill, M. A., Perfield, J. W., Ibdah, J. A., et al. (2013) · Physiological Genomics · doi:10.1152/physiolgenomics.00038.2013 · Cited by 40
Douglas, G., Mehta, V., Zen, A. A. H., Akoumianakis, I., Goel, A., Rashbrook, V. S., Trelfa, L., Donovan, L., Drydale, E., Chuaiphichai, S., et al. (2019) · Cardiovascular Research · doi:10.1093/cvr/cvz263 · Cited by 38
Self-citationSega, F. V. D., Aquila, G., Fortini, F., Vaccarezza, M., Secchiero, P., Rizzo, P., & Campo, G. C. (2017) · BioFactors · doi:10.1002/biof.1359 · Cited by 35
Ho, D. H., Burch, M. L., Musall, B., Musall, J. B., Hyndman, K. A., & Pollock, J. S. (2016) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00016.2016 · Cited by 34
Qin, Z., Hou, X., Weisbrod, R. M., Seta, F., Cohen, R. A., & Tong, X. (2014) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2014.02.019 · Cited by 34
Zheng, H., Xu, N., Zhang, Z., Wang, F., Xiao, J., & Ji, X. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.823975 · Cited by 33
Redox Control of Vascular Function
Galley, J. C., & Straub, A. C. (2017) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.117.309945 · Cited by 31
Role of ROS and autophagy in the pathological process of atherosclerosis
Zhu, L., Liao, Y., & Jiang, B. (2024) · Journal of Physiology and Biochemistry · doi:10.1007/s13105-024-01039-6 · Cited by 26
Deletion of NoxO1 limits atherosclerosis development in female mice
Buchmann, G., Schürmann, C., Warwick, T., Schulz, M. H., Spaeth, M., Müller, O. J., Schröder, K., Jo, H., Weißmann, N., & Brandes, R. P. (2020) · Redox Biology · doi:10.1016/j.redox.2020.101713 · Cited by 26
The Ins and Outs of Small GTPase Rac1 in the Vasculature
Marinković, G., Heemskerk, N., van Buul, J. D., & de Waard, V. (2015) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.115.223610 · Cited by 25
Goo, Y., Son, S., Yechoor, V. K., & Paul, A. (2016) · Journal of the American Heart Association · doi:10.1161/jaha.115.002663 · Cited by 25
Endothelial Reprogramming in Atherosclerosis
Zhang, L., Xin, W., & Hong, L. (2024) · Bioengineering · doi:10.3390/bioengineering11040325 · Cited by 23
Natural Bioactive Compounds Targeting NADPH Oxidase Pathway in Cardiovascular Diseases
Sofiullah, S. S. M., Murugan, D. D., Muid, S. A., Wu, Y. S., Kadir, S. Z. S. A., Abas, R., Ridzuan, N. R. A., Zamakshshari, N. H., & Choy, K. W. (2023) · Molecules · doi:10.3390/molecules28031047 · Cited by 28
NADPH-oxidases as potential pharmacological targets for thrombosis and depression comorbidity
Amadio, P., Sandrini, L., Zarà, M., Barbieri, S. S., & Ieraci, A. (2024) · Redox Biology · doi:10.1016/j.redox.2024.103060 · Cited by 25
Wang, J., Zhang, P., Liu, M., Huang, Z., Yang, X., Ding, Y., Liu, J., Cheng, X., Xu, S., He, M., et al. (2023) · BMC Medicine · doi:10.1186/s12916-023-02807-9 · Cited by 23
Capillaries as a Therapeutic Target for Heart Failure
Yoshida, Y., Shimizu, I., & Minamino, T. (2022) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.rv17064 · Cited by 21
Gomes, D. J., Velosa, A. P. P., Okuda, L. S., Fusco, F. B., da Silva, K. S., Pinto, P. R., Nakandakare, E. R., Corrêa‐Giannella, M. L., Woods, T. M., Brimble, M. A., et al. (2016) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2016.07.001 · Cited by 22
Szostak, J., Boué, S., Talikka, M., Guedj, E., Martin, F. P., Phillips, B. W., Ivanov, N. V., Peitsch, M. C., & Hoeng, J. (2017) · Food and Chemical Toxicology · doi:10.1016/j.fct.2017.01.013 · Cited by 20
Ho, F., Watson, A. M. D., Elbatreek, M. H., Kleikers, P. W. M., Khan, W., Sourris, K. C., Dai, A., Jha, J. C., Schmidt, H. H. H. W., & Jandeleit-Dahm, K. A. M. (2022) · Scientific Reports · doi:10.1038/s41598-022-15706-5 · Cited by 19
α-lipoic acid in patients with autosomal dominant polycystic kidney disease
Lai, S., Petramala, L., Muscaritoli, M., Cianci, R., Mazzaferro, S., Mitterhofer, A. P., Pasquali, M., D’Ambrosio, V., Carta, M., Ansuini, M., et al. (2019) · Nutrition · doi:10.1016/j.nut.2019.110594 · Cited by 20
Jiang, T., Zhang, Y., Guo, Z., Ren, H., Hu, W., Yao, Q., Huo, Y., Qi, Y., & Huang, K. (2025) · Advanced Science · doi:10.1002/advs.202502639 · Cited by 18
Functional Heterogeneity of Nadph Oxidases in Atherosclerotic and Aneurysmal Diseases
Kigawa, Y., Miyazaki, T., Lei, X., Kim‐Kaneyama, J., & Miyazaki, A. (2016) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.33431 · Cited by 18
Yousefian, M., Hosseinzadeh, H., Hayes, A. W., Hadizadeh, F., & Karimi, G. (2021) · Journal of Pharmacy and Pharmacology · doi:10.1093/jpp/rgab109 · Cited by 20
Kerr, P. M., Tam, R., Narang, D., Potts, K. G., McMillan, D., McMillan, K., & Plane, F. (2012) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/y2012-075 · Cited by 18
Vascular Stenosis: An Introduction
Thiriet, M., Delfour, M. C., & Garon, A. (2015) · Springer eBooks · doi:10.1007/978-3-642-37078-6_32 · Cited by 18
Graton, M. E., Potje, S. R., Troiano, J. A., do Vale, G. T., Perassa, L. A., Nakamune, A. C. D. M. S., Tirapelli, C. R., Bendhack, L. M., & Antoniali, C. (2018) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2018.12.026 · Cited by 16
Endothelial NADPH oxidase 2: when does it matter in atherosclerosis?
Haendeler, J., Eckers, A., Lukosz, M., Unfried, K., & Altschmied, J. (2012) · Cardiovascular Research · doi:10.1093/cvr/cvs106 · Cited by 15
Theofilis, P., Vordoni, A., & Kalaitzidis, R. (2022) · Life · doi:10.3390/life12101663 · Cited by 14
Redox mechanisms of the beneficial effects of heme oxygenase in hypertension
Chan, E. C., Dusting, G. J., Liu, G., & Jiang, F. (2014) · Journal of Hypertension · doi:10.1097/hjh.0000000000000179 · Cited by 14
PHACTR1modulates vascular compliance but not endothelial function: a translational study
Wood, A., Antonopoulos, A. S., Chuaiphichai, S., Kyriakou, T., Diaz, R., Al-Hussaini, A., Marsh, A.-M., Sian, M., Meisuria, M., McCann, G. P., et al. (2022) · Cardiovascular Research · doi:10.1093/cvr/cvac092 · Cited by 13
Self-citationBrunßen, C., Giebe, S., Hofmann, A., Brux, M., & Morawietz, H. (2017) · Applied In Vitro Toxicology · doi:10.1089/aivt.2016.0037 · Cited by 13
Zhong, C., Deng, K., Lang, X., Shan, D., Xie, Y., Pan, W. Q., & Yu, J. (2025) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2025.108864 · Cited by 15
Sustained hypertension despite endothelial-specific eNOS rescue in eNOS-deficient mice
Suvorava, T., Stegbauer, J., Thieme, M., Pick, S., Friedrich, S., Rump, L. C., Hohlfeld, T., & Kojda, G. (2015) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2015.01.152 · Cited by 12
Gyamfi, M. A., Goettsch, C., Kamhieh‐Milz, J., Chen, L., Pfefferkorn, A. M., Hofmann, A., Brunßen, C., Müller, G. M., Walther, T., Ashraf, M., et al. (2024) · Antioxidants · doi:10.3390/antiox13040500 · Cited by 11
Shimada, K., Hirano, E., Kimura, T., Fujita, M., & Kishimoto, C. (2012) · Experimental Biology and Medicine · doi:10.1258/ebm.2012.012022 · Cited by 10
Aging and Antithrombotic Treatment
Valeriani, E., Bartimoccia, S., Pignatelli, P., & Pastori, D. (2023) · Antioxidants and Redox Signaling · doi:10.1089/ars.2023.0373 · Cited by 11
Coremans, C., Delporte, C., COTTON, F. J., van de Borne, P., Boudjeltia, K. Z., & Antwerpen, P. V. (2021) · Molecules · doi:10.3390/molecules26175264 · Cited by 8
Waeckel, L., Badier‐Commander, C., Damery, T., Köhler, R., Sansilvestri, P., Simonet, S., Vayssettes‐Courchay, C., Wulff, H., & Félétou, M. (2014) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-014-1644-6 · Cited by 6
Role of Matricellular Proteins in Endothelial Cell Inflammation and Atherosclerosis
Aithabathula, R. V., Kumar, S., & Singla, B. (2025) · Antioxidants · doi:10.3390/antiox14111338 · Cited by 5
Isoform-Selective Nox Inhibitors: Advances and Future Perspectives
Dustin, C. M., Cifuentes-Pagano, E., & Pagano, P. J. (2023) · Springer eBooks · doi:10.1007/978-3-031-23752-2_21 · Cited by 5
Upadhyay, R. K., Kumar, K., Vishwakarma, V. K., Singh, N., Narang, R., Parakh, N., Yadav, M., Yadav, S., Kumar, S., Goyal, A., et al. (2024) · Current Vascular Pharmacology · doi:10.2174/0115701611308870240910115023 · Cited by 6
Reactive oxygen species, oxidative stress, and cardiovascular diseases
Sharifpanah, F., & Sauer, H. (2016) · Wiley eBooks · doi:10.1002/9781118832431.ch17 · Cited by 5
Farra, Y. M., Sabnis, S., Matz, J., Wilker, H. I. B., Williams, V. A., Trejo, O., Kim, H. H., Rivera, C. F., Vlahos, J., Ramkhelawon, B., et al. (2025) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.125.320908 · Cited by 5
Qi, X., Huang, Q., Wang, S., Qiu, L., Chen, X., Ouyang, K., & Chen, Y. (2023) · Frontiers in Medicine · doi:10.3389/fmed.2023.1185303 · Cited by 4
Redox Proteomics Analysis of Atherosclerotic Aortas: Application of the “OxICAT” Method
Makridakis, M., & Vlahou, A. (2022) · Methods in molecular biology · doi:10.1007/978-1-0716-1924-7_39 · Cited by 3
NADPH Oxidase 5 (NOX5) Upregulates MMP-10 Production and Cell Migration in Human Endothelial Cells
Marqués, J., Ainzúa, E., Orbe, J., Martínez-Azcona, M., Martínez‐González, J., & Zalba, G. (2024) · Antioxidants · doi:10.3390/antiox13101199 · Cited by 3
Oxidase Interactions in Cardiovascular Disease
Youn, J. Y., Siu, K. L., Li, Q., Harrison, D. G., & Cai, H. “. (2014) · Springer eBooks · doi:10.1007/978-3-642-30018-9_43 · Cited by 3
Implications of Inflammation in Aging and Age-Related Diseases
Tan, B. L., & Norhaizan, M. E. (2021) · Springer eBooks · doi:10.1007/978-3-030-82859-2_5 · Cited by 2
NOX2 as a Biomarker of Academic Performance: Evidence from University Students during Examination
Nocella, C., D’Amico, A., Cangemi, R., FOSSATI, C., Pigozzi, F., Mannacio, E., Cammisotto, V., Bartimoccia, S., Castellani, V., Sarto, G., et al. (2024) · Antioxidants · doi:10.3390/antiox13050551 · Cited by 2
Zhao, K., Zhu, G.-Z., Li, H.-Z., Gao, J.-W., Tu, C., Wu, D.-Z., Huang, Y., Han, D., Chen, X., Wu, L.-Y., et al. (2024) · The Journals of Gerontology Series A · doi:10.1093/gerona/glae271 · Cited by 1
Metadata
- Authors
- Douglas, G., Bendall, J. K., Crabtree, M. J., Tatham, A. L., Carter, E. E., Hale, A. B., & Channon, K. M.
- Affiliations
- John Radcliffe Hospital (GB)
- University of Oxford (GB)
- Corresponding author
- Douglas, Gillian
- Venue
- Cardiovascular Research
- Publisher
- Oxford University Press (OUP)
- Published
- 2012-01-27
- Volume
- 94
- Issue
- 1
- Pages
- 20-29
- ISSN
- 0008-6363 (ISSN-L)
- 1755-3245
- PMC
- PMC3307381
- OpenAlex
- W1988097865
- Cited by
- 111
- References
- 28
- Citations by year
- 2026: 5 · 2025: 5 · 2024: 8 · 2023: 7 · 2022: 12 · 2021: 5 · 2020: 1 · 2019: 6 · 2018: 8 · 2017: 13 · 2016: 10 · 2015: 6 · 2014: 10 · 2013: 10 · 2012: 5
- FWCI
- 6.65
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- other-oa
- Locations
- Cardiovascular Research (publishedVersion, other-oa)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Funders
- Wellcome Trust (090532)
- British Heart Foundation (PG/05/141/20098, RG/07/003/23133, RG/12/5/29576)
- Topics
- Health Sciences › Medicine › Physiology (medical) › Nitric Oxide and Endothelin Effects
- Life Sciences › Immunology and Microbiology › Immunology › Atherosclerosis and Cardiovascular Diseases
- Life Sciences › Immunology and Microbiology › Immunology › Neutrophil, Myeloperoxidase and Oxidative Mechanisms
- Keywords
- NOX2, NADPH oxidase, atherosclerosis initiation, macrophage recruitment, ApoE-deficient mice, VCAM-1, reactive oxygen species, endothelial dysfunction, angiotensin II, aortic root lesions
- MeSH terms
- NADPH Oxidase 2, Angiotensin II, Animals, Aortic Diseases, Apolipoproteins E, Blood Pressure, Chemotaxis, Disease Models, Animal, Humans, Macrophages, Membrane Glycoproteins, Mice, Transgenic, Superoxides, Time Factors, Signal Transduction, Up-Regulation, Mice, Knockout, Disease Progression, Vascular Cell Adhesion Molecule-1, NADPH Oxidases, Endothelial Cells, Atherosclerosis, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review